Observational studyDigestive diseases and sciences2023

Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.

Amandeep Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.